These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
633 related items for PubMed ID: 17581228
41. Hormone therapy and cardiovascular disease--still much to be learnt. Mikkola TS, Ylikorkala O. Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832 [Abstract] [Full Text] [Related]
42. HRT and the primary prevention of cardiovascular disease. Stevenson JC. Maturitas; 2007 May 20; 57(1):31-4. PubMed ID: 17383835 [Abstract] [Full Text] [Related]
43. Can menopause be considered an independent risk factor for cardiovascular disease? Mercuro G, Zoncu S, Cherchi A, Rosano GM. Ital Heart J; 2001 Oct 20; 2(10):719-27. PubMed ID: 11721715 [Abstract] [Full Text] [Related]
44. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy. Antonicelli R, Olivieri F, Morichi V, Urbani E, Mais V. Int J Cardiol; 2008 Nov 12; 130(2):140-6. PubMed ID: 18617278 [Abstract] [Full Text] [Related]
45. [Cardiovascular disease as a current threat of older women. Relation to estrogens]. Zárate A, Saucedo R, Basurto L, Martínez C. Ginecol Obstet Mex; 2007 May 12; 75(5):286-92. PubMed ID: 17849811 [Abstract] [Full Text] [Related]
46. WHI risks: any relevance to menopause management? Burger HG. Maturitas; 2007 May 20; 57(1):6-10. PubMed ID: 17368974 [Abstract] [Full Text] [Related]
47. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Rossouw JE. Maturitas; 2005 May 16; 51(1):51-63. PubMed ID: 15883110 [Abstract] [Full Text] [Related]
48. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Sohrabji F. Ann N Y Acad Sci; 2005 Jun 16; 1052():75-90. PubMed ID: 16024752 [Abstract] [Full Text] [Related]
49. [Hormone replacement therapy and cardiovascular pathology in menopause]. Micheli S, Marcucci R, Farsi A, Abbate R. Ann Ital Med Int; 1998 Jun 16; 13(1):37-46. PubMed ID: 9642841 [Abstract] [Full Text] [Related]
50. Interactions between melatonin and estrogen may regulate cerebrovascular function in women: clinical implications for the effective use of HRT during menopause and aging. Harrod CG, Bendok BR, Hunt Batjer H. Med Hypotheses; 2005 Jun 16; 64(4):725-35. PubMed ID: 15694689 [Abstract] [Full Text] [Related]
51. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause]. Scarabin PY, Plu-Bureau G. Arch Mal Coeur Vaiss; 1993 Feb 16; 86(2):243-8. PubMed ID: 8363427 [Abstract] [Full Text] [Related]
52. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data]. Gaspard U. J Gynecol Obstet Biol Reprod (Paris); 2008 Jun 16; 37(4):340-5. PubMed ID: 18249506 [Abstract] [Full Text] [Related]
53. Update on hormones, menopause, and heart disease: evaluating professional responses to the Women's Health Initiative. Derry PS. Health Care Women Int; 2008 Aug 16; 29(7):720-37. PubMed ID: 18663631 [Abstract] [Full Text] [Related]
57. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum. Harman SM. Fertil Steril; 2014 Apr 16; 101(4):887-97. PubMed ID: 24680648 [Abstract] [Full Text] [Related]
58. [Hormone replacement therapy and cardiovascular risk in postmenopausal women]. Kovacev-Zavisić B, Icin T, Kovacev N. Med Pregl; 2009 Apr 16; 62 Suppl 3():85-90. PubMed ID: 19702123 [Abstract] [Full Text] [Related]
59. Role of oestrogen in the central regulation of autonomic function. Saleh TM, Connell BJ. Clin Exp Pharmacol Physiol; 2007 Sep 16; 34(9):827-32. PubMed ID: 17645624 [Abstract] [Full Text] [Related]